What was the median EV/EBITDA multiple for Medical Devices in 2025?

The median EV/EBITDA multiple for Medical Devices acquisitions in 2025 was 13.36x, based on 13 disclosed transactions. The p25-p75 range was 5.52x to 15.8x.

What was the median EV/Revenue multiple for Medical Devices in 2025?

The median EV/Revenue multiple for Medical Devices acquisitions in 2025 was 4.48x, based on 31 disclosed transactions. The p25-p75 range was 1.18x to 6.7x.

2025M&A Transaction Multiples

Medical Devices Multiples - 2025

Sourced from 31 publicly disclosed Medical Devices acquisitions in 2025. Public records only (SEC EDGAR + verified press releases).

EV / EBITDA

13.4x

median · p25 5.5x - p75 15.8x · n=13

EV / Revenue

4.5x

median · p25 1.2x - p75 6.7x · n=31

Value your Medical Devices business

Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.

Medical Devices multiples by year

2025 · 13.36x EBITDA 2024 · 15.15x EBITDA 2023 · 13.7x EBITDA 2022 · 17.03x EBITDA 2021 · 16.5x EBITDA 2020 · 25.9x EBITDA 2019 · 13.7x EBITDA 2018 · 15.7x EBITDA

Other verticals - 2025 multiples

Food Manufacturing· 7.4x EBITDA Healthcare IT· 26.55x EBITDA Industrial Equipment· 11x EBITDA IT Services· 9.04x EBITDA Laboratory Services· 13.8x EBITDA Mental Health· 8.6x EBITDA Metal Fabrication· 29.52x EBITDA Oil Gas Services· 6.75x EBITDA Other· 15.16x EBITDA Other Healthcare· 16x EBITDA Other Manufacturing· 10.66x EBITDA Other Professional Services· 13.1x EBITDA Other Technology· 21.38x EBITDA Pharmacy· 11.15x EBITDA SaaS· 35.3x EBITDA Specialty Contractor· 9.19x EBITDA Wholesale Distribution· 9.61x EBITDA

Data sourced from 31 disclosed Medical Devices M&A transactions in 2025. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →